Drug Profile
Enterovirus A vaccine - Beijing Vigoo Biological
Alternative Names: EV71 vaccine- Beijing Vigoo Biological; HFMD vaccine - Beijing Vigoo Biological; Vero cell-based vaccine - Beijing Vigoo BiologicalLatest Information Update: 17 May 2015
Price :
$50
*
At a glance
- Originator Beijing Vigoo Biological
- Developer Beijing Vigoo Biological; Jiangsu Provincial Center for Disease Control and Prevention
- Class Enterovirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Enterovirus A infections
Most Recent Events
- 17 May 2015 No development reported - Phase-III for Enterovirus A infections (Prevention) in China (Parenteral)
- 01 May 2013 Beijing Vigoo Biological completes a phase II trial for Enterovirus A infections (Prevention) in China (NCT01679665)
- 14 Mar 2013 Beijing Vigoo Biological completes a phase III trial for Enterovirus A infections (Prevention) in China (NCT01508247)